A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery
A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery
复制标题
DOI：
10.1158/0008-5472.can-04-1948
复制
发表时间：
2004-11-01
期刊：
影响因子：
11.2
通讯作者：
Lin, CT
中科院分区：
文献类型：
--
作者：
Lee, TY;Wu, HC;Lin, CT
鼻咽癌（NPC）是生活在中国南方、台湾和新加坡的中国人常见的癌症。据报道，鼻咽癌早期放疗的5年生存率高达90% ~ 95%，但在晚期病例中，即使同时使用化疗和放疗，生存率仍然很低
Nasopharyngeal carcinoma (NPC) is a common cancer among Chinese living in southern China, Taiwan, and Singapore. The 5-year survival rate in the early stage of NPC has been reported as high as 90 to 95% with the use of radiotherapy, but in the advanced cases, even with the use of both chemotherapy and radiotherapy, the survival rate is still